Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,922,209 papers from all fields of science
Search
Sign In
Create Free Account
PF-06647263
Known as:
Antibody-drug Conjugate PF-06647263
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Aminoglycosides
Antibodies, Monoclonal, Murine-Derived
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
A phase I study of PF-06647263, a novel EFNA4-ADC, in patients with metastatic triple negative breast cancer.
I. Garrido-Laguna
,
I. Krop
,
+10 authors
R. Hassan
2017
Corpus ID: 79727228
2511Background: PF-06647263 is an anti-Ephrin-A4 (EFNA4) antibody drug conjugate (ADC) composed of a humanized mAb, a hydrazone…
Expand
2015
2015
Abstract 5425: An anti-Ephrin-A4 calicheamicin conjugate effectively targets triple-negative breast and ovarian tumor-initiating cells to result in sustained tumor regression
M. Damelin
,
A. Bankovich
,
+25 authors
S. Dylla
2015
Corpus ID: 76195963
Triple-negative breast cancer (TNBC) and ovarian cancer comprise heterogeneous tumors, and neither targeted therapies nor…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE